1hon MSN
Q4 2024 Management View Greg Lehmkuhl, CEO, highlighted the company's accomplishments, including executing the largest REIT IPO of all time in 2024, reducing leverage below 5x, and achieving ...
The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by ...
NSDL, India's largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
18h
Hosted on MSNHow To Invest in the ThoughtSpot IPO: A Beginner’s GuideInvesting in ThoughtSpot’s IPO might be a good move to add to your portfolio, It has beating out competitors other analytics ...
Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.
Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...
A brief history of Netflix stock. Netflix was founded in 1997 as a competitor to Blockbuster, operating a DVD-by-mail rental ...
Nearly half of the new-age companies listed since 2021 are trading below their IPO price. This and more in today’s ETtech Top ...
Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...
Paytm, Delhivery, and Honasa are the top losers, while Zomato and PB Fintech have stood up successfully against the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results